HEALTHglobal
Novo uses FDA voucher to win speedy approval of higher-dose Wegovy
Single source
Updated 2 hours ago
First seen March 20, 2026 07:14:09Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.